Page last updated: 2024-09-03

ginsenoside rh2 and Corneal Neovascularization

ginsenoside rh2 has been researched along with Corneal Neovascularization in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, C; Ge, HM; Jiang, Q; Li, KR; Li, XM; Yao, J; Yao, MD; Yu, Q; Zhang, XP	1

Other Studies

1 other study(ies) available for ginsenoside rh2 and Corneal Neovascularization

Article	Year
Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents; Cornea; Corneal Neovascularization; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; Ice; Male; MAP Kinase Signaling System; Mice, Inbred ICR; Phosphoproteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2018

Article

Year

Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:7

Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents; Cornea; Corneal Neovascularization; Ginsenosides; Human Umbilical Vein Endothelial Cells; Humans; Ice; Male; MAP Kinase Signaling System; Mice, Inbred ICR; Phosphoproteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2018